Pharmaceutical Drug Targets and Diseases

From Proteopedia

Revision as of 10:52, 24 September 2010

AstraZeneca’s Nexium

{{#tree:id=siteTree| The following is a list of major pharmaceutical compound targets, organized by disease.

• • Alzheimer’s Disease
    • Acetylcholinesterase
    • Amyloid Beta
    • Gamma-Secratase
    • Glutamate Receptor
      • Glutamate receptor (GluA2)
      • Glutamate Receptor

• • Anemia
    • Erythropoietin

• • Asthma and other Pulmonary Disease States
    • Beta-2-Andrenergic Receptor
    • Leukotriene Receptor

• • Atherosclerosis & Hypercholesterolemia (Elevated Cholesterol)
    • HMG-CoA Reductase
    • 5-Lipoxygenase Activating Protein

• • Autoimmune Diseases
    • Tumor Necrosis Factor Receptor

• • Blood Clots & Thrombic Events
    • P2Y12

• • Cancer
    • Caspases
      • Caspase-6
      • Caspase-7 Dynamics
      • Caspase-9 Regulation
    • DEBS
    • Farnesoid X Receptor
    • Growth Factors & Receptors
      • Epidermal Growth Factor
        • Epidermal Growth Factor
        • Epidermal Growth Factor Receptor
      • Hepatocyte Growth Factor Receptor
      • Human Epidermal Growth Factor Receptor 2
      • Insulin-Like Growth Factor
        • Insulin-Like Growth Factor-1
        • Insulin-Like Growth Factor-1 Receptor
      • Vascular Growth Factor
        • Vascular Endothelial Growth Factor
        • Vascular Endothelial Growth Factor Receptor
    • Hypoxia Inducible Factor (HIF)
    • Heat Shock Protein 90
    • Kinases
      • Cell Division Cycle 7-Related Protein Kinase
      • Mammalian Target of Rapamycin
      • Mitogen-Activated Proteins
        • Mitogen-Activated Protein Kinase
        • Mitogen-Activated Protein Kinase Kinase
        • Mitogen-Activated Protein Kinase Kinase Kinase
          • c-Raf
      • Phosphatidylinositol 3-Kinase
      • SRC
    • p53
    • Taxol Information
    • Tumor-Necrosis Factor Apoptosis-Inducing Ligand

• • Compromised Immune System
    • Granulocyte-macrophage colony-stimulating factor

• • Delivery Systems
    • Targeted Drug Delivery

• • Diabetes & Hypoglycemia
    • Insulin Information
    • Peroxisome Proliferator-Activated Receptors

• • Digestive Diseases
    • Proton Pump

• • Erectile Dysfunction
    • cGMP-Specific Phosphodiesterase Type 5

• • Hypertension & Congestive Heart Failure
    • Angiotensin-Converting Enzyme
    • Calcium Channel

• • Inflammation & Rheumatoid Arthritis
    • Cyclooxygenase

• • Metabolic Disorders
    • Acid-beta-glucosidase
    • [[Molecular_playground/beta_2_microglobulin|ß-2 Microglobulin]
    • Protective Protein/Cathepsin A (PPCA)
    • Protective Protein/Cathepsin A (PPCA) 2
    • Treatment_of_Gaucher_disease
    • Velaglucerase

]

• • Schizophrenia, Bipolar Depression, Insomnia, and Anxiety Disorders
    • Dopamine Receptor
    • Andrenergic Receptor
    • Histamine Receptor
    • Opioid Receptor

• • Viral Infection
    • HIV
      • Reverse Transcriptase
    • Influenza
      • Avian Influenza Neuraminidase, Tamiflu and Relenza
      • Influenza hemagglutinin
      • Influenza A M2 Transmembrane Domain
      • Proton Channels featuring a morph of the M2 proton channel of influenza.
      • Tamiflu
      • Relenza

}}